Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 02

330P - Effect of radiotherapy in deep inspiration in patients with left breast cancer: Does the size of the target area affect the dose for the most crucial organs at risk?

Date

21 Oct 2023

Session

Poster session 02

Topics

Tumour Site

Breast Cancer

Presenters

Zoltan Locsei

Citation

Annals of Oncology (2023) 34 (suppl_2): S278-S324. 10.1016/S0923-7534(23)01258-9

Authors

Z. Locsei1, B. Nagy2, T.B. Brunner3, L.C. Mangel4

Author affiliations

  • 1 -, Universitätsklinik für Strahlentherapie-Radioonkologie, 7624 - Graz/HU
  • 2 Radiotherapy, PTE-AOK - Pecs University Medical School - Institute of Oncotherapy, 7624 - Pécs/HU
  • 3 Radiation Oncology, Graz Medical University, 8036 - Graz/AT
  • 4 Institute Of Oncotherapy, PTE-AOK - Pecs University Medical School - Institute of Oncotherapy, 7624 - Pécs/HU

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 330P

Background

After radiotherapy (RT) to the left breast, the long-term risk of developing various cardiovascular diseases may increase. In our study, we present how deep inspiration treatment changes the doses of organs at risk (OAR), especially the heart. Furthermore, we examined if there is a relationship between the size of the irradiated target area and the dose on the heart.

Methods

From May 2016 to August 2020, 503 patients with left-sided breast cancer underwent RT at our institute. Since May 2018, we have treated our patients in deep breathing (DIBH) using the “voluntary breath-hold” technique. We compared the Dmean and Dmax values for the most critical OAR (left lung, heart, left ventricle, LAD-left anterior descending artery) based on the two treatment methodologies. Subsequently, both groups were then further subdivided into whether the treatment was given by standard fractionation or hypofractionation and created 3-3 groups based on the size of the target area (PTV).

Results

In patients treated with normal fractionation in DIBH vs. without, the doses of the OARs were the following: lung Dmean: 9.3 Gy vs. 9.96 Gy (p=0.029), left ventricle Dmean: 3.52 Gy vs. 7.56 Gy (p=2.69E-27), heart Dmean: 2.78 vs. 5.31 (p=1.11E-24), LAD Dmean 12.17 vs. 25.91 Gy (p=4.63E-24) respectively. In the hypofractionated group with vs. without DIBH the values were lung Dmean: 7.43 Gy vs. 8.08 Gy (p=0.17), left ventricle Dmean: 3.48 Gy vs 6.4 Gy (p=2.64E-10), heart Dmean: 2.64 vs 4.62 (p=2.96E-08), LAD Dmean 11.46 vs 18.35 Gy (p=3.37E-06) respectively. In the standard fractionated group, the average doses for each structure decreased mostly in women with large breast sizes after DIBH treatment. Generally, as the breast size increases, the values of the left ventricle, heart, and LAD increase, whilst the values of the lungs decrease. Although, a significant difference could only be detected in a few categories.

Conclusions

DIBH RT of the left breast significantly reduces radiation exposure to crucial OAR than free-breathing radiation therapy. At the same time, the coverage of the target area does not change, and our results suggest that this benefit is most pronounced in patients with large breast sizes.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.